Russian professional tennis player Maria Sharapova has been suspended for two years for an anti-doping rule violation, the International Tennis Federation announced Wednesday. Her "period of ineligibility" will be backdated to Jan. 26, 2016, the day Sharapova tested positive for the heart disease drug, meldonium, at the Australian Open.
Sharapova responded to the announcement almost immediately with a public statement saying that she would not accept the "unfairly harsh" suspension and that she planned to appeal the decision. She has maintained that she did not intentionally seek the blood flow-boosting drug for performance enhancement, but for health issues:
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.
Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.